Genmab ADR (NASDAQ:GMAB) currently has a daily average trading volume of 742.06K but it saw 1014965 shares traded in last market. With a market cap of 14.43B USD, the company’s current market price of $22.73 came falling about -0.18 while comparing to the previous closing price of $22.77. In past 52 weeks, the stock remained buoying in the range of price level as high as $32.89 and as low as $22.39. In the recent trading on the day, stock has struck highest price mark of $22.67 while lowest mark touched by it was $22.97.
Taking a look at 20-day trading activity of Genmab ADR (GMAB) gives us an average price of $23.46, while its current price level is -30.89% below from 52-week high level whereas it is 1.52% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $25.48 while that of 200 days or SMA-200 reads an average of $27.63. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.36% during that period while stretching the period over a month that decreases to 1.27%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 29.38 which implies that the stock is in oversold territory.
Over the week, GMAB’s stock price is moving 0.58% up while it is -5.33% when we observe its performance for the past one month. Year-to-date it is -28.61% down and over the past year, the stock is showing a downside performance of -23.21%.
Currently, Genmab ADR’s total number of outstanding shares is 653.30M. Company’s return on investment (ROI) stands at 17.43% and return on equity (ROE) at 18.45%. It has a price to earnings ratio (P/E ratio) of 18.66 while having a 16.20 of forward P/E ratio. Stock’s beta reads 0.98. Stock has a price to book (P/B) ratio of 3.24 while price to sale or P/S ratio amounts to 5.25. Its return on asset (ROA) is 15.61% on average.
